Netherlands destroying 17 million swine flu vaccine doses

 

The Netherlands is destroying more than 17 million unused doses of swine flu vaccine that were nearing their expiry date and that it could not resell, the health ministry said Tuesday."We have started destroying" the vaccines, health ministry spokeswoman Inge Freriksen told AFP. "In the coming months, 17.8 million doses will be destroyed because the expiry date is approaching."The Dutch government bought 31 million doses of vaccine against the A(H1N1) virus at the height of the global swine flu outbreak last year. About 11 million were used.

Related

  • The United States will this week reach a landmark in the fight against swine flu as 100 million doses of vaccine become available to the public, Health Secretary Kathleen Sebelius said Thursday."By the end of this week, we will have 100 million doses of H1N1 vaccine available to the people. In fact, we're at 99.5 million doses today," Sebelius told reporters at a briefing on the swine flu pandemic.

  • China has inoculated over 3.78 million people against swine flu and distributed over 26 million doses of vaccine to ward off a serious outbreak of the disease, the government said Sunday.Over 33 million doses produced by eight Chinese pharmaceutical companies have been approved for distribution, with another 100 million more doses expected in the first quarter of next year, the health ministry said.

  • The French government fought off Monday criticism that it had poorly planned its swine flu vaccine programme after it bought more doses than needed and announced plans to sell surplus stock.France bought 94 million doses of the vaccines for the A(H1N1) virus, expecting to provide its population with two doses each, but only five million people have been vaccinated and one dose has been found to be sufficient.

  • Health officials are recalling hundreds of thousands of doses of swine flu vaccine after tests indicated they may not be potent enough to protect against the virus.

  • Health officials are recalling hundreds of thousands of doses of swine flu vaccine after tests indicated they may not be potent enough to protect against the virus.

  • British drug maker GlaxoSmithKline has announced that US regulators have approved its swine flu vaccine for adults in the United States."The US Food and Drug Administration (FDA) has approved a... license application for its unadjuvanted influenza A (H1N1) pandemic vaccine," GSK said in a statement received on Wednesday."The United States Department of Health and Human Services has placed an order to fill 7.6 million doses of unadjuvanted H1N1 pandemic vaccine from GSK, which will contribute to the approximately 250 million doses secured by the US government."

  • The first doses of swine flu vaccine may all be the nasal spray version, government health officials said Friday. The government has said a trickle of vaccine will be available in early October, but on Friday they defined the size of that trickle -- an estimated 3.4 million doses.

  • More than 22 million doses of swine flu vaccine are available now, and most Americans should soon find it easier to get their dose, U.S. health officials said Tuesday.

  • A week after 800,000 doses of children's swine flu vaccine were recalled in the United States for losing their potency, a second vaccine maker recalled its A(H1N1) nasal spray for the same reason.MedImmune announced late Tuesday that it was "voluntarily recalling unused doses of 13 specific lots of influenza A(H1N1) 2009 Monovalent Vaccine Live, Intranasal due to a slight decrease in potency."There is no safety concern with the lots that are being recalled," it added in a statement.

  • SWIFTWATER, Pa. (AP) -- The federal government originally promised 120 million doses of swine flu vaccine by now. Only 13 million have come through....

 
DJI: 10447.93 1.22% |S&P 500: 1104.51 1.3% |FTSE: 5428.15 1.05% |Nikk.: 9114.13 0.56% |DAX: 6134.62 0.83% |HSI: 20971.50 0.49% |
FX: EUR/GBP: 1.1997 | USD/EUR: 1.2892 | JPY/USD: 84.375 | Commodities: Gold: 1247.00 | Crude - CLH09.NYM: 0.00 |